These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
91 related items for PubMed ID: 8588390
21. [Level of compliance in the treatment of sleep obstructive apnea syndrome with nasal continuous positive pressure]. Terán Santos J, Quintana González JI, Morato Arnáiz A, Lázaro Asegurado L, García Arroyo I. Rev Clin Esp; 1996 Aug; 196(8):509-14. PubMed ID: 8984536 [Abstract] [Full Text] [Related]
22. Hypertension and obstructive sleep apnea. Ambulatory blood pressure monitoring before and with nCPAP-therapy. Lies A, Nabe B, Pankow W, Kohl FV, Lohmann FW. Z Kardiol; 1996 Aug; 85 Suppl 3():140-2. PubMed ID: 8896321 [Abstract] [Full Text] [Related]
23. [Detecting blood pressure variation using spectral analysis in obstructive sleep apnea syndrome with and without nCPAP therapy]. Brandenburg U, Greinke S, Penzel T, Peter JH. Pneumologie; 1995 Mar; 49 Suppl 1():116-20. PubMed ID: 7617592 [Abstract] [Full Text] [Related]
24. [Improvement of health-related quality of life in patients with obstructive sleep apnea syndrome under CPAP therapy]. de Zeeuw J, Baberg HT, Kempkens DJ, Schmalz O, Duchna HW, Orth M, Kugler J, Schultze-Werninghaus G, Rasche K. Med Klin (Munich); 2003 Apr 15; 98(4):181-7. PubMed ID: 12715141 [Abstract] [Full Text] [Related]
25. Quality of life in patients with obstructive sleep apnea: effect of nasal continuous positive airway pressure--a prospective study. D'Ambrosio C, Bowman T, Mohsenin V. Chest; 1999 Jan 15; 115(1):123-9. PubMed ID: 9925072 [Abstract] [Full Text] [Related]
26. Sleep fragmentation indices as predictors of daytime sleepiness and nCPAP response in obstructive sleep apnea. Bennett LS, Langford BA, Stradling JR, Davies RJ. Am J Respir Crit Care Med; 1998 Sep 15; 158(3):778-86. PubMed ID: 9731004 [Abstract] [Full Text] [Related]
27. [Treatment of primary and secondary therapy failure in patients with sleep apnea treated with nasal CPAP]. Becker H, Fett I, Nees E, Peter JH, von Wichert P. Pneumologie; 1991 May 15; 45 Suppl 1():301-5. PubMed ID: 1866413 [Abstract] [Full Text] [Related]
28. [Differential therapeutic aspects in treatment of obstructive sleep apnea syndrome]. Mayer G, Hochban W, Meier-Ewert K. Nervenarzt; 1995 Apr 15; 66(4):293-8. PubMed ID: 7783817 [Abstract] [Full Text] [Related]
29. Adherence to nCPAP in patients with coronary disease and sleep apnea without sleepiness. Sampol G, Rodés G, Romero O, Jurado MJ, Lloberes P. Respir Med; 2007 Mar 15; 101(3):461-6. PubMed ID: 16919928 [Abstract] [Full Text] [Related]
30. [Nasal CPAP therapy in obstructive sleep apnea syndrome: patient compliance]. Karrer W, Rothe TB, Ryckx A, Keller U. Schweiz Med Wochenschr; 2000 Sep 16; 130(37):1291-7. PubMed ID: 11045033 [Abstract] [Full Text] [Related]
34. Quality adjusted life years added by treatment of obstructive sleep apnea. Tousignant P, Cosio MG, Levy RD, Groome PA. Sleep; 1994 Feb 16; 17(1):52-60. PubMed ID: 8191203 [Abstract] [Full Text] [Related]
35. Effects of CPAP on vigilance and related functions in patients with the sleep apnea/hypopnea syndrome. Douglas NJ, Engleman HM. Sleep; 2000 Jun 15; 23 Suppl 4():S147-9. PubMed ID: 10893090 [Abstract] [Full Text] [Related]